Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Pediatr Infect Dis J. 2017 Dec;36(12):e322–e327. doi: 10.1097/INF.0000000000001691

Table 3.

Crude and adjusted hazard ratios for death during first 2-years of MDR TB treatment in three provinces, South Africa, 2005–2008.

Bivariate Modelsa Multivariable
Modelb (N=372)


Factor N HR (95% CI) aHR (95% CI)
HIV Status HIV+ vs. HIV− 395 2.20 (1.22 3.97) 2.28 (1.11 4.68)
Sex Male vs. Female 394 3.01 (1.73 5.24) 2.69 (1.47 4.91)
Age >7 years vs. ≤7 years 395 0.55 (0.33 0.93) 0.56 (0.29 1.06)
Resistance Type PreXDR/XDR TB vs. MDRc TB 345 1.55 (0.81 2.97) Not included
Weight Status Underweightd vs. normal 372 2.59 (1.37 4.87) 2.65 (1.37 5.13)
Culture+ > 6mose Yes vs. No 395 1.24 (0.70 2.18) Not included

Abbreviations: MDR, multidrug resistant; TB, tuberculosis; HR, hazard ratio; aHR, adjusted hazard ratio; CI, confidence interval; HIV, human immunodeficiency virus; XDR, extensively drug resistant; mos, months.

a

Bivariate Cox proportional hazard models.

b

Multivariable Cox proportional hazard model, stratified on province and year of diagnosis.

c

Includes rifampicin mono-resistance.

d

Weight for age adjusted Z-score >2 standard deviations below the mean.

e

Any positive culture results 6 months or after start of first DR TB treatment regimen.